Central regions | Finance, business

U.S.’ NeoPhotonics builds on Rusnano investment and opens R&D center in Moscow

21 May '13
Last week NeoPhotonics, a US-based developer of optoelectronics for high-speed communications networks, opened its R&D center and Russia/Eastern Europe sales office in Moscow, a year after it received a capital injection from Rusnano, Russia’s state-owned nanotech investment corporation, East-West Digital News, the international resource on Russian digital industries, reported yesterday, citing a Rusnano source.

Tim Jenks, chairman and CEO of NeoPhotonics, told Rusnano that he hopes the move will help his company enhance its “research presence and the potential for production of advanced PIC-based solutions.”

In April 2012, the US firm announced the closing of a $39.8 million private placement transaction with Russia’s nanotech giant. The investment, which gave Rusnano about 17% of NeoPhotonics’ newly-issued common shares, was aimed at setting up photonic integrated circuit (PIC)-based production in Russia and has helped provide a fast track for broader adoption of the US firm’s high-speed, agile, and coherent PIC technologies in this country.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content

Locations: Moscow

Tags: Rusnano (423) / R&D center (23) / NeoPhotonics (1) / sales office (0) / Tim Jenks (0) /

Latest News: Central regions
17 May '19 | Finance, business | Telecoms, media
16 May '19 | Technology & innovation | Finance, business
14 May '19 | Transport, logistics | Finance, business
13 May '19 | Technology & innovation

Feature stories

4 Apr '19
Russian scientists have come up with what they say is...
29 Jan '19
Russian biologists and biophysicists have developed...
2 Nov '18
Drawing upon in-depth interviews, the book channels...
Search (News archive - 21348)
Independent Software Developers Forum
Marchmont News

Latest News

20 May '19
An intelligent cardiovascular diseases diagnostics...
17 May '19
MTS, one of Russia’s main mobile operators, has...
16 May '19
The Skolkovo Foundation and AstraZeneca, an...

Most read stories from last week

20 May '19
An intelligent cardiovascular diseases diagnostics...